IRF3 and neoplasm: A recent study published in Cancer Cell revealed that p53 mutant can directly bind to the downstream molecule TBK1 of STING, thereby inhibiting the formation of the STING/TBK1/IRF3 complex and enabling the immune escape of tumor cells (43).